ICD-10 Coding for Malignant Tumor of Prostate(C79.51, C79.51B, C79.51S)
Explore comprehensive ICD-10 coding guidelines for malignant tumor of the prostate, including primary and ancillary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Malignant Tumor of Prostate
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C61 | Malignant neoplasm of prostate | Use when there is active prostate cancer, confirmed by clinical tests. |
|
| C79.51 | Secondary malignant neoplasm of bone | Use when prostate cancer has metastasized to the bone. |
|
| Z85.46 | Personal history of malignant neoplasm of prostate | Use when the patient has a history of prostate cancer with no current treatment or evidence of disease. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMalignant Tumor of Prostate
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Malignant Tumor of Prostate.
Omitting metastasis documentation.
Impact
Clinical: Inaccurate treatment planning., Regulatory: Non-compliance with coding guidelines., Financial: Potential loss of reimbursement.
Mitigation
Review imaging reports for metastasis., Include metastasis status in notes.
Coding historical cancer as active.
Impact
Reimbursement: Incorrect reimbursement for active treatment., Compliance: Non-compliance with coding standards., Data Quality: Inaccurate patient records.
Mitigation
Verify current treatment status and PSA levels.
Active vs. Historical Coding
Impact
Risk of coding historical cancer as active.
Mitigation
Regularly review treatment status and PSA levels.